Wearable for Critical Limb Ischemia and Peripheral Arterial Disease

Vibrato Medical, Inc. is pioneering a noninvasive wearable therapeutic ultrasound device aimed at treating Critical Limb Ischemia (CLI) and Peripheral Arterial Disease (PAD). This innovative technology is designed to enhance tissue perfusion, alleviate symptoms, and ultimately save limbs without the need for surgical interventions or skin incisions. By leveraging decades of research and advancements in ultrasound technology, Vibrato's device promotes vasodilation and the growth of collateral vessels, which are critical for improving blood flow in affected patients. The device's wearability and ease of use allow patients to undergo treatment conveniently from their homes, potentially increasing compliance and overall treatment effectiveness.

Currently, Vibrato Medical is initiating prospective clinical trials to evaluate the safety and efficacy of its technology in patients with advanced PAD and CLI. These trials are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health, underscoring the scientific credibility of their approach. The therapeutic ultrasound technology has been validated through various animal and clinical studies, demonstrating its ability to induce vasodilation and promote angiogenesis, which are essential processes for improving blood circulation in patients suffering from these debilitating conditions.

United States

Our mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. 

The Company has developed the first wearable therapeutic ultrasound device for the noninvasive, outpatient treatment of peripheral arterial disease. It is designed to promote vasodilation, collateral vessel growth and angiogenesis, and restore perfusion.

Vibrato Medical, Inc.

Company Details